Bladder cancer screening and monitoring of 4,4′-methylenebis(2- chloroaniline) exposure among workers in Taiwan

Urology

Volumn 66, Issue 2, 2005, Pages 305-310

  Chen, Hong I ^a   Liou, Saou Hsing ^b   Loh, Ching Hui ^b   Uang, Shi Nian ^b   Yu, Yi Chun ^b   Shih, Tung Sheng ^b  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

4,4' METHYLENEBIS(2 CHLOROANILINE); ANILINE DERIVATIVE; NUCLEAR MATRIX PROTEIN; NUCLEAR MATRIX PROTEIN 22; TUMOR MARKER;

ADULT; ANALYTIC METHOD; ARTICLE; BLADDER CANCER; CANCER SCREENING; CARCINOGENICITY; CONCENTRATION (PARAMETERS); CYSTOSCOPY; ECHOGRAPHY; FEMALE; HEMATURIA; HUMAN; INTRAVENOUS PYELOGRAPHY; MALE; MEASUREMENT; MONITORING; OCCULT BLOOD TEST; OCCUPATIONAL EXPOSURE; OCCUPATIONAL SAFETY; PREVALENCE; PRIORITY JOURNAL; SKIN ABSORPTION; STATISTICAL SIGNIFICANCE; TAIWAN; UNITED STATES; URINE CYTOLOGY; WORKER;

ADULT; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; MALE; MASS SCREENING; METHYLENEBIS(CHLOROANILINE); OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; TAIWAN; URINARY BLADDER NEOPLASMS;

EID: 23744444417     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2005.02.031     Document Type: Article

References (36)

1. H.D. Humes, H.L. DuPont, L.B. Gardner Kelley's Textbook of Internal Medicine 2000 Williams & Wilkins Lippincott
2. Department of Health Annual report of cancer registry 2004 DOH Taiwan, ROC
3. L. Rehn Blasengeschwülste bei Fuchsin-arbeitern Arch Klin Chir 50 1895 588 600
4. R.A. Case, M.E. Hosker, D.B. McDonald Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical industry. Part I. The role of aniline, benzidine, alpha-naphthylamine, and beta-naphthylamine Br J Ind Med 11 1954 75 104
5. IARC Overall Evaluations of Carcinogenicity An updating of IARC Monographs Volumes 1 to 42, Suppl 7 1987 IARC Lyon, France
6. A.H. Goroll, L.A. May, A.G. Mulley Primary Care Medicine 2000 Williams & Wilkins Philadelphia, Lippincott
7. Agency for Toxic Substances and Disease Registry (ATSDR) Toxicological profile for 4,4′-methylenebis(2-chloroaniline) (MBOCA) 1994 U.S. Department of Health and Human Services, Public Health Service Atlanta, Georgia
8. HSDB 4,4′-Methylenebis(2-chloraniline) Hazardous Substances Data Bank 1991 National Library of Medicine, National Toxicology Information Program Bethesda, Maryland October 17
9. H.R. Hosein, P.B. Van Roosmalen Acute exposure to methylene-bis-ortho chloroaniline (MOCA) Am Ind Hyg Assoc J 39 1978 496 497
10. E.F. Stula, J.R. Barnes, H. Sherman Urinary bladder tumors in dogs from 4,4′-methylene-bis(2-chloroaniline) (MOCA) J Environ Pathol Toxicol 1 1977 31 50
11. C. Kommineni, D.H. Groth, I.J. Frocket Determination of the tumorigenic potential of methylene-bis-orthochloroaniline J Environ Pathol Toxicol 2 1979 149 171
12. A.B. Russfield, F. Homburger, E. Boger The carcinogenic effect of 4,4′-methylene-bis-(2-chloroaniline) in mice and rats Toxicol Appl Pharmacol 31 1975 47 54
13. E.F. Stula, H. Sherman, J.A. Zapp Jr Experimental neoplasia in rats from oral administration of 3,3′-dichlorobenzidine, 4,4′-methylene-bis(2- chloroaniline), and 4,4′-methylene-bis(2-methylaniline) Toxicol Appl Pharmacol 31 1975 159 176
14. E.B. Murray, J.W. Edwards Micronuclei in peripheral lymphocytes and exfoliated urothelial cells of workers exposed to 4,4′-methylenebis-(2- chloroaniline) (MOCA) Mutat Res 446 1999 175 180
15. IARC: IARC monographs on the evaluation of the carcinogenic risk of chemicals to man: some aromatic amines, hydrazine and related substances, n-nitroso compounds and miscellaneous alkylating agents Vol. 4 1974 World Health Organization, International Agency for Research on Cancer Lyon, France 65 71
16. E. Ward, W. Halperin, M. Thun Screening workers exposed to 4,4′-methylenebis-(2-chloroaniline) for bladder cancer by cystoscopy. In: International Conference on Bladder Cancer Screening in High-Risk Groups, September 13-14, 1989 J Occup Med 32 1990 865 868
17. E. Ward, W. Halperin, M. Thun Bladder tumors in two young males occupationally exposed to MBOCA Am J Ind Med 14 1988 267 272
18. Occupational Safety and Health Administration Method 24 2nd ed. 1990 U.S. Department of Labor, Occupational Safety and Health Administration, Organic Methods Evaluation Branch, OSHA Analytical Laboratory Salt Lake City, Utah
19. E.G. Freg, S. Penman Nuclear matrix proteins reflect cell type of origin in cultured human cells Proc Natl Acad Sci USA 85 1998 121 124
20. E. Ward, A.B. Smith, W. Halperin 4,4′-Methylenebis(2-chloroaniline) an unregulated carcinogen Am J Ind Med 12 1987 537 549
21. B. Chin, M.C. Tobes, S.S. Han Absorption of 4,4′-methylenebis(2- chloroaniline) by human skin Environ Res 32 1983 167 178
22. J. Cocker, A.R. Boobis, D.S. Davis Determination of the N-acetyl metabolites of 4,4′-methylene dianiline and 4,4′-methylene-bis(2- chloroaniline) in urine Biomed Env Mass Spec 17 1988 161 167
23. J. Cocker, A.R. Boobis, H.K. Wilson Evidence that a beta-n-glucuronide of 4,4′-methylene-bis(2-chloroaniline) (MBOCA) is a major urinary metabolite in man implications for biological monitoring Br J Ind Med 47 1990 154 161
24. Y. Ichikawa, M. Yoshida, A. Okayama Biological monitoring for workers exposed to 4,4′-methylenebis(2-chloroaniline) Am Ind Hyg Assoc J 51 1990 5 7
25. NIOSH Industrial hygiene survey report, Parkway Products, Inc., Cincinnati, Ohio. Contract No. IWS-144.13 1986 National Institute for Occupational Safety and Health, Department of Health and Human Services Cincinnati, Ohio Document No. PB87-222360
26. R.P. Nelson New concepts in staging and follow-up of bladder carcinoma Urology 21 1985 105 108
27. A.L. Linch, G.B. O'Connor, J.R. Barnes Methylene-bis-ortho-chloroaniline (MOCA) evaluation of hazards and exposure control Am Ind Hyg Assoc J 32 1971 802 819
28. J. Landman, Y. Chang, E. Kavaler Sensitivity and specificity of NMP22, telomerase, and BTA in the detection of human bladder cancer Adult Urol 52 1998 398 402
29. C. Zippe, L. Pandrangi, A. Agarwal NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer J Urol 161 1999 162 165
30. D.S. Stampfer, G.A. Carpinito, J. Rodriguez-Villanueva Evaluation of NMP22 in the detection of transitional cell carcinoma of bladder J Urol 159 1998 394 398
31. A.W. Partin, R.H. Getzenberg, M.J. CarMichael Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer Cancer Res 53 1993 744 748
32. W.E. Fayerweather, H.A. Smith, W.J. Vogler Bladder health survey of MOCA workers (MOCA) 1992 December 28. http://www.mocahome.org/bladderhealth.html/.
33. K.L. Cheever, D.E. Richards, W.W. Weigel 4,4′-Methylene-bis(2- chloraniline) (MOCA) comparison of macromolecular adduct formation after oral or dermal administration in the rat Fundam Appl Toxicol 14 1990 273 283
34. M.E. Kugler-Stegmeier, U. Friederich, U. Graf Genotoxicity of aniline derivatives in various short-term tests Mutat Res 211 1989 279 289
35. G.T. Vaughan, R.S. Kenyon Monitoring for occupational exposure to 4,4′-methylenebis(2-chloroaniline) by gas chromatographic-mass spectrometric analysis of haemoglobin adducts, blood, plasma and urine J Chromatogr B Biomed Appl 678 1996 197 204
36. 32P postlabeling assay Fundam Appl Toxicol 30 1996 138 144